Patch test informed consent form: position statement by European Academy of Dermatology and Venereology Task Force on Contact Dermatitis

Patch test informed consent form: position statement by European Academy of Dermatology and Venereology Task Force on Contact Dermatitis
Position Statement
Balato, E. Scala, F. Ayala, A. Bauer, M.-N. Crépy, M. Gonçalo, J. Duus Johansen, S.M. John, T. Rustemeyer, N. Wagner, M. Wilkinson, A. Giménez-Arnau
Journal of The European Academy of Dermatology and Venereology, 19 July 2021
Abstract
Background
To our knowledge, an international consensus is lacking regarding the development of an adequate informed consent form for a patch test (PT) and the information that should be included in such document.
Objectives
The aim of the study was to reach a consensus on the specific points that need to be addressed in a PT consent form.
Methods
A Delphi survey, comprising 2 rounds and 1 final discussion, was used to gather and analyse data, which was conducted over the Internet. Each statement that reached a consensus with the respondents (9 expert dermatologists from Europe) was defined as a median consensus score (MED) of ≥7 and agreement among panelists as an interquartile range (IQR) of ≤3. All study participants were members of the EADV task force on contact dermatitis.
Results
The expert panel addressed several topics that should be included in an informed consent form for a PT: introduction, preparation for PT, testing procedure, allowed activities, adverse events and additional authorizations.
Conclusions
Our results assess recommendations regarding points to be contained in an informed consent form for a PR. Future actions towards standardization and harmonization of this specific consent form are needed.